BioCorRx (BICX) Depreciation & Amortization (CF) (2011 - 2026)

BioCorRx has disclosed Depreciation & Amortization (CF) across 16 years of filings, most recently posting $11195.0 for Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $11195.0, down 54.94% year-over-year; the trailing twelve-month figure through Mar 2026 was $30355.0 (down 40.8% YoY), and the FY2025 annual result was $44003.0, up 32.76% from the prior year.
• Depreciation & Amortization (CF) came in at $11195.0 for Q1 2026 at BioCorRx, up from -$124804.0 in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $71987.0 in Q3 2025 to a low of -$124804.0 in Q4 2025.
• The 5-year median for Depreciation & Amortization (CF) is $6862.0 (2022), against an average of $8388.3.
• Peak annual rise in Depreciation & Amortization (CF) reached 972.04% in 2025, while the deepest fall reached 1059.81% in 2025.
• BioCorRx's Depreciation & Amortization (CF) stood at $6862.0 in 2022, then fell by 2.14% to $6715.0 in 2023, then jumped by 93.64% to $13003.0 in 2024, then sank by 1059.81% to -$124804.0 in 2025, then soared by 108.97% to $11195.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $11195.0 (Q1 2026), -$124804.0 (Q4 2025), and $71987.0 (Q3 2025), per Business Quant data.